多发性骨髓瘤中的T细胞功能障碍
Linyu Cai1, Liping Zuo1, Guangqi Wang1
1Institute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, 430022, People's Republic of China.
ImmunoTargets and therapy
|September 17, 2025
概括
多发性骨髓瘤免疫疗法显示出希望,但面临来自骨髓免疫抑制环境的挑战. 本综述探讨了T细胞在免疫逃避中的作用,并提出了提高治疗疗效的策略.
科学领域:
- 血液恶性瘤研究研究
- 免疫疗法机制 免疫疗法机制
- 癌症免疫学 癌症免疫学
背景情况:
- 多发性骨髓瘤 (MM) 是一种血细胞恶性瘤,由于抗CD38抗体,CAR-T细胞和TCEs等免疫疗法改善了存活率.
- 骨髓微环境带来了重大的免疫抑制挑战,限制了MM目前免疫疗法的有效性.
- 了解免疫规避机制对于开发克服这些局限性并改善患者治疗结果的策略至关重要.
研究的目的:
- 系统地审查涉及多发性骨髓瘤免疫规避的T细胞亚型.
- 突出最近关于非传统T细胞和MM免疫反应中的代谢控制的研究.
- 讨论针对MM进展中的免疫逃避机制的新型治疗策略.
主要方法:
- 对T细胞亚型和多发性骨髓瘤中免疫逃避的最新研究进行系统性文献综述.
- 对聚焦于骨髓微环境免疫抑制作用的研究进行分析.
- 对非传统T细胞,代谢重编程和治疗干预措施的研究进行审查.
主要成果:
- 鉴定出各种T细胞亚型,在MM微环境中促进免疫逃避.
- 强调了在MM进展中免疫监测和抑制之间的不平衡.
- 详细介绍了最近对影响免疫细胞功能和治疗点的代谢途径的详细发现.
结论:
- 免疫抑制性骨髓微环境是有效的MM免疫疗法的关键障碍.
- 针对T细胞功能障碍,代谢重编程和免疫逃避策略对于增强MM治疗至关重要.
- 对非传统T细胞和代谢控制的进一步研究为多发性骨髓瘤的新疗法开发提供了有希望的途径.
更多相关视频
10:04Establishment of a Human Multiple Myeloma Xenograft Model in the Chicken to Study Tumor Growth, Invasion and Angiogenesis
Published on: May 1, 2015
13.5K
05:32Multimodal Bioluminescent and Positronic-emission Tomography/Computational Tomography Imaging of Multiple Myeloma Bone Marrow Xenografts in NOG Mice
Published on: January 7, 2019
7.2K
相关概念视频
T Cell Activation and Clonal Selection
14.8K
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Naive T cells that have not yet encountered an antigen express two primary CD...
14.8K
T Cell Types and Functions
2.2K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
2.2K
Abnormal Proliferation
5.1K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.1K
